Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Waldenstrom Macroglobulinemia"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 786
Tytuł:
Aggressive Lymphoplasmacytic Neoplasm With an Unusual In-frame Deletion of MYD88 Associated With TRAF3 and TP53 Mutations and Complex Karyotype.
Autorzy:
Yan M; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Meyerson H; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Oduro KA; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Shetty S; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Yoest J; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2024 Feb; Vol. 32 (1), pp. 5-10. Date of Electronic Publication: 2023 Apr 24.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, B-Cell, Marginal Zone*/pathology
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/genetics
Waldenstrom Macroglobulinemia*/pathology
Humans ; Myeloid Differentiation Factor 88/genetics ; TNF Receptor-Associated Factor 3/genetics ; NF-kappa B/genetics ; Mutation ; Karyotype ; Tumor Suppressor Protein p53/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Rare Case of Non-IgM Lymphoplasmacytic Lymphoma with Unusual Lack of Immunoglobulin Light Chain Production.
Autorzy:
Yin J; Department of Pathology, Temple University Hospital, Philadelphia, PA, USA.
Bains A; Department of Pathology, Temple University Hospital, Philadelphia, PA, USA.
Alsammak M; Department of Pathology, Temple University Hospital, Philadelphia, PA, USA.
Fu JJ; Department of Pathology, Temple University Hospital, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2024 Mar 04; Vol. 25, pp. e940963. Date of Electronic Publication: 2024 Mar 04.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Waldenstrom Macroglobulinemia*/diagnosis
Lymphoma, B-Cell*
Lymphoma*
Female ; Humans ; Aged ; Immunoglobulin A ; Immunoglobulin G
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A Rare Case of Subcutaneous Amyloidoma Associated with Localized Lymphoplasmacytic Lymphoma: Diagnostic Challenges and Treatment Considerations.
Autorzy:
Vivian LF; Department of Pathology, ASST Santi Paolo e Carlo, Milan, Italy.
Marcelis L; Department of Pathology, UZ Leuven, University Hospitals, Leuven, Belgium.; Department of Imaging and Pathology, Translational Cell and Tissue Research Lab, KU Leuven, Leuven, Belgium.
Leoni E; Department of Pathology, ASST Valle Olona, Busto Arsizio, Italy.
De Bruecker Y; Department of Radiology, Imelda Hospital, Bonheiden, Belgium.
Maes H; Department of Hematology, Imelda Hospital, Bonheiden, Belgium.
Pierré E; Department of Pathology, Imelda Hospital, Bonheiden, Belgium.
Ballaux FM; Department of Pathology, Imelda Hospital, Bonheiden, Belgium.
Tousseyn T; Department of Pathology, UZ Leuven, University Hospitals, Leuven, Belgium.; Department of Imaging and Pathology, Translational Cell and Tissue Research Lab, KU Leuven, Leuven, Belgium.
Pokaż więcej
Źródło:
The American journal of case reports [Am J Case Rep] 2023 Oct 02; Vol. 24, pp. e940789. Date of Electronic Publication: 2023 Oct 02.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Amyloidosis*/diagnosis
Amyloidosis*/therapy
Lymphoma, B-Cell, Marginal Zone*/diagnosis
Lymphoma, B-Cell, Marginal Zone*/therapy
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/therapy
Plasmacytoma*/diagnosis
Plasmacytoma*/therapy
Soft Tissue Neoplasms*
Female ; Humans ; Middle Aged ; Amyloid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Hematological entities with plasmacytic differentiation: a case report.
Autorzy:
Inamdar A; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104-4238, USA. .
Bhattacharyya S; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104-4238, USA.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Sep 26; Vol. 17 (1), pp. 429. Date of Electronic Publication: 2023 Sep 26.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Plasmacytoma*/diagnosis
Waldenstrom Macroglobulinemia*/diagnosis
Female ; Humans ; Middle Aged ; In Situ Hybridization, Fluorescence ; Immunoglobulin M ; Cell Differentiation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ibrutinib-Induced Pancreatitis in Patients with Waldenstrom Macroglobulinemia
Autorzy:
Büyükkurt N; Başkent University Faculty of Medicine, Department of Internal Medicine, Division of Hematology, Ankara, Türkiye
Soydaş B; Başkent University Faculty of Medicine, Department of Gastroenterology, Ankara, Türkiye
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 May 29; Vol. 40 (2), pp. 141-142. Date of Electronic Publication: 2023 May 17.
Typ publikacji:
Journal Article
MeSH Terms:
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/drug therapy
Humans ; Piperidines/adverse effects ; Agammaglobulinaemia Tyrosine Kinase ; Adenine/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Waldenström macroglobulinemia with secondary pure red cell aplasia in a patient with metastatic castrate resistant prostate cancer receiving an immune checkpoint inhibitor: a case report.
Autorzy:
Kumar V; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Chapel Hill, NC, 27599-7305, USA.
Montgomery ND; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
van Deventer HW; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Whang YE; Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, 170 Manning Drive, Chapel Hill, NC, 27599-7305, USA. .; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. .
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 May 28; Vol. 17 (1), pp. 220. Date of Electronic Publication: 2023 May 28.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/drug therapy
Red-Cell Aplasia, Pure*/chemically induced
Red-Cell Aplasia, Pure*/drug therapy
Red-Cell Aplasia, Pure*/complications
Anemia*/chemically induced
Prostatic Neoplasms*/complications
Lymphoproliferative Disorders*
Humans ; Male ; Aged ; Immune Checkpoint Inhibitors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mycoplasma infection mimicking a malignancy in a waldenstrom macroglobulinemia patient.
Autorzy:
Wu J; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China.
He D; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China.
Yu F; Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.
Huang Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.
Bian M; Department of Hematology, The Second People's Hospital of Huai'an, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huaian, 223001, China.
Yu C; Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, Ministry of Education, Zhejiang University School of Medicine, Hangzhou, 310000, Zhejiang, China.
Liu J; Hangzhou Xixi Hospital, Zhejiang University of Traditional Chinese Medicine, Hangzhou, 310000, Zhejiang, China.
Cai Z; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China.; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China.; Institute of Hematology, Zhejiang University, Hangzhou, 310000, Zhejiang, China.; Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University Medical Center, Hangzhou, 310000, China.
Zhao Y; Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310000, China. .; Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 310000, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 Apr 07; Vol. 23 (1), pp. 219. Date of Electronic Publication: 2023 Apr 07.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*
Waldenstrom Macroglobulinemia*/diagnosis
Humans ; Fluorodeoxyglucose F18 ; Positron Emission Tomography Computed Tomography/methods ; Positron-Emission Tomography ; Radiopharmaceuticals ; Diagnosis, Differential ; Neoplasms
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Bilateral central retinal vein occlusion as an initial presentation of Waldenström macroglobulinemia: a case report.
Autorzy:
Shrestha S; Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal. .
Poddar E; Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.
Bashyal B; Department of Internal Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Adhikari A; Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.
Pathak P; Department of Pathology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Acharya S; Department of Internal Medicine, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Sapkota S; Department of Internal Medicine, Saint Agnes Hospital, Maryland, USA.
Bhattarai A; Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.
Pant SR; Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.
Shrestha A; Department of Pathology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Feb 20; Vol. 17 (1), pp. 59. Date of Electronic Publication: 2023 Feb 20.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/drug therapy
Retinal Vein Occlusion*/diagnosis
Retinal Vein Occlusion*/drug therapy
Retinal Vein Occlusion*/etiology
Humans ; Male ; Adult ; Bortezomib
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Patient preferences regarding treatment options for Waldenström's macroglobulinemia: A discrete choice experiment.
Autorzy:
Amaador K; Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Nieuwkerk PT; Department of Medical Psychology, Academic Medical Center, Amsterdam, The Netherlands.
Minnema MC; Department of Hematology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands.
Kersten MJ; Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Vos JMI; Amsterdam UMC, University of Amsterdam, Department of Hematology, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Lymphoma and Myeloma Center Amsterdam (LYMMCARE), Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 3376-3386. Date of Electronic Publication: 2022 Jul 26.
Typ publikacji:
Journal Article
MeSH Terms:
Waldenstrom Macroglobulinemia*/therapy
Peripheral Nervous System Diseases*
Humans ; Patient Preference ; Nausea ; Vomiting
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treatment of relapsed and refractory Waldenstrom Macroglobulinemia.
Autorzy:
Amaador K; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Kersten MJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Minnema MC; Department of Hematology, University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands.
Vos JMI; Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2023 Jan; Vol. 64 (1), pp. 30-41. Date of Electronic Publication: 2022 Oct 25.
Typ publikacji:
Journal Article
MeSH Terms:
Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/genetics
Antineoplastic Agents*/therapeutic use
Lymphoma, Non-Hodgkin*/drug therapy
Humans ; Antibodies, Monoclonal/therapeutic use ; Mutation ; Myeloid Differentiation Factor 88/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Single-cell profiles reveal tumor cell heterogeneity and immunosuppressive microenvironment in Waldenström macroglobulinemia.
Autorzy:
Sun H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Fang T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Wang T; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Yu Z; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Gong L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Wei X; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Wang H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
He Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Liu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Yan Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Sui W; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Xu Y; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Yi S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
Qiu L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. .; Tianjin Institutes of Health Science, Tianjin, 301600, China. .
Hao M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. .; Tianjin Institutes of Health Science, Tianjin, 301600, China. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2022 Dec 09; Vol. 20 (1), pp. 576. Date of Electronic Publication: 2022 Dec 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ecosystem*
Waldenstrom Macroglobulinemia*/genetics
Waldenstrom Macroglobulinemia*/pathology
Humans ; Bone Marrow/pathology ; Tumor Microenvironment ; B-Lymphocytes/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider.
Autorzy:
Butelet A; Hemostasis and transfusion department, Biology Pathology Center, University hospital of Lille, Lille, France.
Poulain S; Laboratory of Hematology, Biology Pathology Center, CHU of Lille, INSERM UMR-S 1177, Team 4, Cancer Research Institute, Univ. Lille, France.
Jeanpierre E; Hemostasis and transfusion department, Biology Pathology Center, University hospital of Lille, Lille, France.
Srour M; Service des Maladies du Sang, Centre Hospitalier Universitaire de Lille, Lille, France.
Nudel M; Service des Maladies du Sang, Centre Hospitalier Universitaire de Lille, Lille, France.
Chauvet P; Service des Maladies du Sang, Centre Hospitalier Universitaire de Lille, Lille, France.
Bauters A; Hemostasis and transfusion department, Biology Pathology Center, University hospital of Lille, Lille, France.
Susen S; Hemostasis and transfusion department, Biology Pathology Center, University hospital of Lille, Lille, France.
Dupont A; Hemostasis and transfusion department, Biology Pathology Center, University hospital of Lille, Lille, France.
de Charette M; Service des Maladies du Sang, Centre Hospitalier Universitaire de Lille, Lille, France.; Service d'hématologie, Centre Hospitalier Universitaire de la Réunion, Saint Denis, France.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (13), pp. 3100-3104. Date of Electronic Publication: 2022 Sep 13.
Typ publikacji:
Journal Article
MeSH Terms:
von Willebrand Diseases*/diagnosis
von Willebrand Diseases*/drug therapy
von Willebrand Diseases*/etiology
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/drug therapy
Humans ; Neoplasm Recurrence, Local ; Piperidines/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia
Autorzy:
Erçalışkan A; Düzce Atatürk State Hospital, Department of Internal Medicine, Division of Hematology, Düzce, Turkey
Avcı FZ; İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, İstanbul, Turkey
Eşkazan AE; İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Internal Medicine, Division of Hematology, İstanbul, Turkey
Pokaż więcej
Źródło:
Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2022 Dec 01; Vol. 39 (4), pp. 275-276. Date of Electronic Publication: 2022 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/drug therapy
Thrombocytopenia*/chemically induced
Thrombocytopenia*/drug therapy
Humans ; Pyrazoles/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A fatal case of a CD5-positive lymphoplasmacytic lymphoma with associated AL-type amyloidosis.
Autorzy:
Marchand A; Department of Pathology, Naval Medical Center, San Diego, California, USA.
Swalchick WG; Department of Pathology, University of California San Diego Health System, La Jolla, California, USA.; Department of Pathology, Trinity Health, Charleston, South Carolina, USA.
Wang HY; Department of Pathology, University of California San Diego Health System, La Jolla, California, USA.
Pokaż więcej
Źródło:
International journal of laboratory hematology [Int J Lab Hematol] 2022 Dec; Vol. 44 (6), pp. 995-996. Date of Electronic Publication: 2022 May 21.
Typ publikacji:
Case Reports
MeSH Terms:
Lymphoma, B-Cell*/pathology
Waldenstrom Macroglobulinemia*/complications
Waldenstrom Macroglobulinemia*/diagnosis
Immunoglobulin Light-chain Amyloidosis*/complications
Immunoglobulin Light-chain Amyloidosis*/diagnosis
Humans
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The unpredictable erythrocyte deformability alteration in some hematological disorders: How the classification of primary hyperviscosity syndromes could change.
Autorzy:
Caimi G; Department of Health Promotion and Child Care, Internal Medicine and Medical Specialties, Università degli Studi di Palermo, Palermo, Italy.
Carlisi M; Department of Health Promotion and Child Care, Internal Medicine and Medical Specialties, Università degli Studi di Palermo, Palermo, Italy.
Pokaż więcej
Źródło:
Clinical hemorheology and microcirculation [Clin Hemorheol Microcirc] 2023; Vol. 83 (4), pp. 341-349.
Typ publikacji:
Journal Article
MeSH Terms:
Polycythemia Vera*/genetics
Hematologic Diseases*
Paraproteinemias*
Waldenstrom Macroglobulinemia*
Humans ; Erythrocyte Deformability ; Blood Viscosity ; Syndrome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United States.
Autorzy:
Chohan KL; Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Abeykoon JP; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Gertz MA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Kapoor P; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Paulus A; Division of Hematology, Mayo Clinic, Jacksonville, FL, USA.
Ailawadhi S; Division of Hematology, Mayo Clinic, Jacksonville, FL, USA.
Reeder CB; Division of Hematology, Mayo Clinic, Phoenix, AZ, USA.
Witzig TE; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Habermann TM; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Lacy MQ; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Kyle RA; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Go RS; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Paludo J; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Dec; Vol. 63 (12), pp. 2879-2888. Date of Electronic Publication: 2022 Jul 23.
Typ publikacji:
Journal Article
MeSH Terms:
Medicare*
Waldenstrom Macroglobulinemia*
United States/epidemiology ; Humans ; Male ; Aged ; Middle Aged ; Insurance Coverage ; Medically Uninsured ; Medicaid ; Healthcare Disparities ; Insurance, Health
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström Macroglobulinemia.
Autorzy:
Muñoz J; Department of Hematology, Mayo Clinic, Phoenix, AZ 85054, USA.
Paludo J; Department of Hematology, Mayo Clinic, Rochester, MN 55905, USA.
Sarosiek S; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Castillo JJ; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Oct 19; Vol. 11 (20). Date of Electronic Publication: 2022 Oct 19.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/genetics
Waldenstrom Macroglobulinemia*/pathology
Lymphoma, B-Cell*
Humans ; Agammaglobulinaemia Tyrosine Kinase ; Quality of Life ; Protein Kinase Inhibitors/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia.
Autorzy:
Kaedbey R; Department of Hematology, Jewish General Hospital, Montreal, QC H3T 1E2, Canada.
Forward N; Department of Medicine, Dalhousie University/Nova Scotia Health, Halifax, NS B3H 2Y9, Canada.
Sehn LH; Department of Medical Oncology, BC Cancer Centre for Lymphoid Cancer, Vancouver, BC V5Z 4E6, Canada.
Shafey M; Department of Medicine, Division of Hematology, Foothills Medical Centre and University of Calgary, Calgary, AB T2N 2T9, Canada.
Doucette S; Impact Medicom Inc., Toronto, ON M6S 3K2, Canada.
Chen CI; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue, Suite 6-225, Toronto, ON M5G 2M9, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Sep 28; Vol. 29 (10), pp. 7122-7139. Date of Electronic Publication: 2022 Sep 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/diagnosis
Hematopoietic Stem Cell Transplantation*
Humans ; Rituximab/therapeutic use ; Bendamustine Hydrochloride/therapeutic use ; Agammaglobulinaemia Tyrosine Kinase ; Proteasome Inhibitors/therapeutic use ; Quality of Life ; Transplantation, Autologous ; Canada ; Immunoglobulin M/therapeutic use ; Purines/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Waldenström Macroglobulinemia: Mechanisms of Disease Progression and Current Therapies.
Autorzy:
Boutilier AJ; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA.
Huang L; Phillips Exeter Academy, Exeter, NH 03833, USA.
Elsawa SF; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, NH 03824, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Sep 22; Vol. 23 (19). Date of Electronic Publication: 2022 Sep 22.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphoma, B-Cell*/pathology
Waldenstrom Macroglobulinemia*/drug therapy
Waldenstrom Macroglobulinemia*/pathology
Bone Marrow/pathology ; Cytokines/therapeutic use ; Disease Progression ; Humans ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma.
Autorzy:
Baloda V; Department of Pathology, UPMC, Pittsburgh, PA, USA.
Wheeler SE; Department of Pathology, University of Pittsburgh and UPMC, Pittsburgh, PA, USA.
Murray DL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Kohlhagen MC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Vos JA; Department of Pathology, Anatomy and Laboratory Medicine, West Virginia University, Morgantown, WV, USA.
Yatsenko SA; Department of Pathology, University of Pittsburgh and UPMC, Pittsburgh, PA, USA.
Agha ME; Hillman Cancer Center, University of Pittsburgh and UPMC, Pittsburgh, PA, USA.
Djokic M; Department of Pathology, University of Pittsburgh and UPMC, Pittsburgh, PA, USA.
Swerdlow SH; Department of Pathology, University of Pittsburgh and UPMC, Pittsburgh, PA, USA.
Bailey NG; Department of Pathology, University of Pittsburgh and UPMC, Pittsburgh, PA, USA. .
Pokaż więcej
Źródło:
Diagnostic pathology [Diagn Pathol] 2022 Aug 05; Vol. 17 (1), pp. 63. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Heavy Chain Disease*
Leukemia, Lymphocytic, Chronic, B-Cell*/diagnosis
Leukemia, Lymphocytic, Chronic, B-Cell*/genetics
Lymphocytosis*
Lymphoma*
Waldenstrom Macroglobulinemia*/diagnosis
Waldenstrom Macroglobulinemia*/genetics
Waldenstrom Macroglobulinemia*/pathology
Humans ; Mutation ; Myeloid Differentiation Factor 88/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 786

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies